Martin Murphy - Crunchbase Person Profile

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Exits

Unlock for free

Location London, England, United Kingdom
Regions Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation
Investor Stage
obfuscated
obfuscation
Number of Exits
obfuscated
obfuscation

LinkedIn View on LinkedIn

Martin Murphy is based out of London and is on the Board of Directors of Century Therapeutics. Martin previously worked at Syncona Partners as a Co-Founder & Chief Executive Officer. Martin Murphy attended the University of Cambridge.

Personal Investments

Number of Investments

Martin Murphy

invested in

Desktop Genetics

obfuscation

. This investment -

Venture Round - Desktop Genetics

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Desktop Genetics	No	Venture Round - Desktop Genetics	obfuscated obfuscation

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Resolution Therapeutics	Syncona Partners LLP	Yes	Series A - Resolution Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Anaveon	Syncona Partners LLP	—	Series B - Anaveon	obfuscated obfuscation
obfuscated obfuscation	Quell Therapeutics	Syncona Partners LLP	—	Series B - Quell Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Clade Therapeutics	Syncona Partners LLP	Yes	Series A - Clade Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Quell Therapeutics	Syncona Partners LLP	Yes	Series A - Quell Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Neogene Therapeutics	Syncona Partners LLP	Yes	Series A - Neogene Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Quell Therapeutics	Syncona Partners LLP	Yes	Series A - Quell Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Anaveon	Syncona Partners LLP	Yes	Series A - Anaveon	obfuscated obfuscation
obfuscated obfuscation	Autolus	Syncona Partners LLP	—	Series C - Autolus	obfuscated obfuscation
obfuscated obfuscation	Autolus	Syncona Partners LLP	Yes	Series A - Autolus	obfuscated obfuscation